Author Question: Who first described pulmonary tuberculosis in detail? A) Hippocrates of Cos B) Aretaeus the ... (Read 9 times)

corkyiscool3328

  • Hero Member
  • *****
  • Posts: 539
Who first described pulmonary tuberculosis in detail?
 
  A) Hippocrates of Cos
  B) Aretaeus the Cappadocian
  C) Claudius Galen
  D) Susruta

Question 2

Secondary HIV prevention or positive prevention is used when caring for African-American women living with HIV by addressing which behavioral risks? (Select all that apply.)
 
  A) Interpersonal mistrust
  B) Alcoholism
  C) Poor adherence to treatment
  D) Smoking
  E) Compromised self-advocacy in sexual relationships



Shshxj

  • Sr. Member
  • ****
  • Posts: 335
Answer to Question 1

Ans: B
Feedback:
Aretaeus the Cappadocian described pulmonary tuberculosis in detail. Hippocrates of Cos was the first to record the relationship of the external environment to the health of individuals. Claudius Galen described the four humors, introduced many drugs derived from plants, and was the first to describe smallpox. Susruta was a Brahmin physician who associated malaria with the mosquito.

Answer to Question 2

Ans: A, C, E
Feedback:
Advancing the scientific understanding of secondary HIV prevention (what is called positive prevention) in African-American women by exploring ways to address behavioral risk reduction prevents further transmission of HIV and the serious negative psychological consequences of living with HIV disease. African-American women experience disproportionate levels of (1) interpersonal mistrust and fear of disclosure related to perceived stigma, (2) poor adherence to treatment and other health promotion and disease prevention efforts, (3) delay in seeking care related to mental health comorbidities and addiction recovery issues, and (4) compromised self-advocacy in sexual relationships. Alcoholism and smoking are not behavioral risks associated with African-American women living with HIV.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

The newest statin drug, rosuvastatin, has been called a superstatin because it appears to reduce LDL cholesterol to a greater degree than the other approved statin drugs.

Did you know?

When blood is exposed to air, it clots. Heparin allows the blood to come in direct contact with air without clotting.

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

Did you know?

Complications of influenza include: bacterial pneumonia, ear and sinus infections, dehydration, and worsening of chronic conditions such as asthma, congestive heart failure, or diabetes.

For a complete list of videos, visit our video library